Cookson Peirce & Co’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Cookson Peirce & Co's NVS Position: Q3 2026 in Review
Cookson Peirce & Co sold out of Novartis (NVS) in Q3 2026, closing a stake of 283,840 shares — an estimated $44.5M sold.
Cookson Peirce & Co first reported a position in NVS in Q4 2018 and held it in 19 quarters. The position peaked at $44.5M in Q2 2026. 1,561 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Cookson Peirce & Co reported no remaining Novartis position as of Q3 2026 after selling out during the quarter.
- Cookson Peirce & Co sold 283,840 Novartis shares in Q3 2026, an estimated $44.5M.
- Cookson Peirce & Co first reported a position in Novartis in Q4 2018 and held it in 19 quarters.
- Cookson Peirce & Co's Novartis position peaked at $44.5M in Q2 2026.
- 1,561 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Cookson Peirce & Co's 13F filing for Q3 2026, filed 30 Oct 2026.